Fund code: 4001

  • NAV $20.60 -$0.05 / -0.26%
    12-Dec-2024
  • Inception 14-Jun-2018
  • Benchmark 50% S&P 500 Index
    50% MSCI World Small Cap Index
  • Aggregate assets
    (all series)
    $2.980B
    30-Nov-2024
  • MER 1.10%
    31-May-2024
  • Distributions
  • Morningstar category Global Equity
  • Also available through Class US$, Class currency neutral and Class T-Series
  • Get Fund Facts

End investment

Annualized return

Choose a chart type (percentage or dollar)
Choose a predefined chart period
to:

Start NAV

$10.0000

End NAV

$10.4031
Choose a predefined chart period
to:

Calendar returns (%) 30-Nov-2024

YTD 2024 2023 2022 2021 2020 2019
Fund 30.97 22.23 -10.92 19.37 15.81 19.38

Standard period returns (%) 30-Nov-2024

1 mo 3 mo 6 mo 1 yr 3 yr 5 yr Inception
Fund 4.86 7.15 11.94 34.20 13.40 14.63 12.34

Why invest in this fund?

  • A core diversified equity strategy that seeks to invest in the most compelling opportunities across the globe.
  • Provides exposure to both growth and value investment styles, as well as a range of company sizes and regions, with the aim of achieving strong risk-adjusted returns.
  • Managed by experienced portfolio managers and backed by Fidelity’s global research platform.

Risk measures (%) 30-Nov-2024

Fund
Annualized standard deviation 12.13
Beta 0.82
0.91

Risk classification

  1. Low
  2. Low to medium
  3. Medium
  4. Medium to high
  5. High

This fund has a medium volatility rating

Allocation

Asset mix (%)

31-Oct-2024

Country mix (%)

31-Oct-2024

Sector mix (%)

31-Oct-2024
12 months ago Last month Current month
Information Technology 18.3 18.4 18.3
Financials 12.4 15.4 16.0
Industrials 13.3 13.7 13.8
Consumer Disc. 12.6 13.4 12.9
Health Care 13.5 12.4 11.8
Communication Services 9.0 9.8 10.0
Consumer Staples 4.3 4.0 3.8
Energy 6.7 3.9 3.7
Materials 3.8 2.9 2.8
Real Estate 0.1 0.9 1.2
Utilities 1.0 1.1 1.2

Top ten holdings

  1. Meta Platforms
  2. Nvidia
  3. Microsoft
  4. Berkshire Hathaway, Cl. B
  5. Amazon.com
  6. Apple
  7. Eli Lilly and Company
  8. Alphabet, Cl. A
  9. Regeneron Pharmaceuticals
  10. UnitedHealth Group
Total number of holdings 740
Top ten holdings aggregate 24.3%
  1. Meta Platforms
  2. Nvidia
  3. Microsoft
  4. Amazon.com
  5. Eli Lilly and Company
  6. Berkshire Hathaway, Cl. B
  7. Apple
  8. Alphabet, Cl. A
  9. Regeneron Pharmaceuticals
  10. Vertex Pharmaceuticals
Total number of holdings 720
Top ten holdings aggregate 25.9%
  1. Meta Platforms
  2. Nvidia
  3. Microsoft
  4. Amazon.com
  5. Berkshire Hathaway, Cl. B
  6. Eli Lilly and Company
  7. Apple
  8. UnitedHealth Group
  9. Alphabet, Cl. A
  10. Regeneron Pharmaceuticals
Total number of holdings 709
Top ten holdings aggregate 24.4%
  1. Meta Platforms
  2. Microsoft
  3. Apple
  4. Amazon.com
  5. Nvidia
  6. Berkshire Hathaway, Cl. B
  7. UnitedHealth Group
  8. Eli Lilly and Company
  9. Alphabet, Cl. A
  10. Regeneron Pharmaceuticals
Total number of holdings 671
Top ten holdings aggregate 24.2%
View all